TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
IQV

IQVIA Holdings Inc

Healthcare · Diagnostics & Research

238.70$ +2.7% vs. previous close Closing price · As of: Aug 7, 2026

Statements

Segments

US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of IQVIA Holdings Inc (IQV). It shows which part of the business is growing — and which one is holding it back.

Revenue by business segment

Revenue by business segment — IQV
Segment Q1 2025 Q2 2025 Q1 2026 Q2 2026
Research & Development Solutions $2.26B 58.9% $2.37B 58.9% $2.40B 57.7% $2.58B 59.0%
Commercial Solutions $1.57B 41.1% $1.65B 41.1% $1.75B 42.3% $1.79B 41.0%

Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.

Revenue by region

Revenue by region — IQV
Segment Q1 2025 Q2 2025 Q1 2026 Q2 2026
Americas $1.81B 47.2% $1.94B 48.2% $1.98B 47.8% $2.04B 46.7%
Europe and Africa $1.22B 32.0% $1.24B 30.9% $1.36B 32.6% $1.41B 32.3%
Asia-Pacific $798.0M 20.8% $841.0M 20.9% $812.0M 19.6% $920.0M 21.1%

Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.

Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.

Data as of: August 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?